Connor Tsuchida
@connortsuchida.bsky.social
Bioengineer | CRISPR-Cas genome editor
Currently building cell & gene therapies
PhD from Doudna Lab @ UC Berkeley & UCSF
Forbes 30u30 ‘24 | NIH F31
Currently building cell & gene therapies
PhD from Doudna Lab @ UC Berkeley & UCSF
Forbes 30u30 ‘24 | NIH F31
Reposted by Connor Tsuchida
Congratulations to IGI alums @jro-hamilton.bsky.social @connortsuchida.bsky.social & team on the launch of Azalea Therapeutics!
Jennifer Doudna's latest startup, Azalea Therapeutics, launched with $82M. It's based on virus like particles developed by CEO Jenny Hamilton and a new CAR-T trick developed by UCSF's Justin Eyquem. Their goal? The ultimate CRISPR-based in vivo CAR-T. @endpts.com - endpoints.news/jennifer-dou...
Jennifer Doudna startup launches with $82M to apply new CRISPR delivery technology to in vivo CAR-T
Nobel laureate Jennifer Doudna's Azalea Therapeutics raises $82M to develop new CRISPR delivery system for in vivo CAR-T cell therapies targeting blood cancers.
endpoints.news
November 4, 2025 at 5:18 PM
Congratulations to IGI alums @jro-hamilton.bsky.social @connortsuchida.bsky.social & team on the launch of Azalea Therapeutics!
Reposted by Connor Tsuchida
Jennifer Doudna's latest startup, Azalea Therapeutics, launched with $82M. It's based on virus like particles developed by CEO Jenny Hamilton and a new CAR-T trick developed by UCSF's Justin Eyquem. Their goal? The ultimate CRISPR-based in vivo CAR-T. @endpts.com - endpoints.news/jennifer-dou...
Jennifer Doudna startup launches with $82M to apply new CRISPR delivery technology to in vivo CAR-T
Nobel laureate Jennifer Doudna's Azalea Therapeutics raises $82M to develop new CRISPR delivery system for in vivo CAR-T cell therapies targeting blood cancers.
endpoints.news
November 4, 2025 at 1:37 PM
Jennifer Doudna's latest startup, Azalea Therapeutics, launched with $82M. It's based on virus like particles developed by CEO Jenny Hamilton and a new CAR-T trick developed by UCSF's Justin Eyquem. Their goal? The ultimate CRISPR-based in vivo CAR-T. @endpts.com - endpoints.news/jennifer-dou...
Reposted by Connor Tsuchida
Congratulations to @jenniferdoudna.bsky.social @doudna-lab.bsky.social for being named a National Medal of Technology and Innovation laureate alongside 10 other notable scientists and organizations! 🧬
Read more from the White House: ow.ly/iohC50UAyFj
Read more from the White House: ow.ly/iohC50UAyFj
President Biden Honors Nation’s Leading Scientists, Technologists, and Innovators | The White House
Today, President Biden announced the latest recipients of the National Medal of Science and the National Medal of Technology and Innovation—our nation’s
ow.ly
January 6, 2025 at 6:23 PM
Congratulations to @jenniferdoudna.bsky.social @doudna-lab.bsky.social for being named a National Medal of Technology and Innovation laureate alongside 10 other notable scientists and organizations! 🧬
Read more from the White House: ow.ly/iohC50UAyFj
Read more from the White House: ow.ly/iohC50UAyFj
Great to see others corroborate the finding that CRISPR-Cas9 mediated DSBs can lead to chromosomal aberrations (tinyurl.com/yp2b9s7m).
I always thought these findings weren’t meant to cause panic, but rather spur innovative solutions. Interesting to see pifithrin-a treatment do just that!
I always thought these findings weren’t meant to cause panic, but rather spur innovative solutions. Interesting to see pifithrin-a treatment do just that!
Modulation of TCR stimulation and pifithrin-α improves the genomic safety profile of CRISPR-engineered human T cells
www.cell.com/cell-reports...
www.cell.com/cell-reports...
December 23, 2024 at 7:02 PM
Great to see others corroborate the finding that CRISPR-Cas9 mediated DSBs can lead to chromosomal aberrations (tinyurl.com/yp2b9s7m).
I always thought these findings weren’t meant to cause panic, but rather spur innovative solutions. Interesting to see pifithrin-a treatment do just that!
I always thought these findings weren’t meant to cause panic, but rather spur innovative solutions. Interesting to see pifithrin-a treatment do just that!
Reposted by Connor Tsuchida
🚨 The Alker Lab is starting at the University of Rhode Island in early 2025 and we will be hiring! 🚨
If you are interested in marine microbiology, bacterial genetics and/or symbiosis, please consider reaching out! Repost to help spread the word 🪸🧪🧬🌊
If you are interested in marine microbiology, bacterial genetics and/or symbiosis, please consider reaching out! Repost to help spread the word 🪸🧪🧬🌊
November 30, 2024 at 12:14 AM
🚨 The Alker Lab is starting at the University of Rhode Island in early 2025 and we will be hiring! 🚨
If you are interested in marine microbiology, bacterial genetics and/or symbiosis, please consider reaching out! Repost to help spread the word 🪸🧪🧬🌊
If you are interested in marine microbiology, bacterial genetics and/or symbiosis, please consider reaching out! Repost to help spread the word 🪸🧪🧬🌊
Reposted by Connor Tsuchida
We usually think of genetic drift as the predominant stochastic force in evolving populations. But working with some model microbial populations, we found a distinct source of demographic stochasticity that scales (and behaves) differently than drift
Learn more in our new paper 👉 rdcu.be/d07Np
Learn more in our new paper 👉 rdcu.be/d07Np
Asynchronous abundance fluctuations can drive giant genotype frequency fluctuations
Nature Ecology & Evolution - Based on a combination of experiments and modelling, this study shows large stochastic fluctuations in genotype frequencies caused by intrinsic and extrinsic...
rdcu.be
November 22, 2024 at 3:46 PM
We usually think of genetic drift as the predominant stochastic force in evolving populations. But working with some model microbial populations, we found a distinct source of demographic stochasticity that scales (and behaves) differently than drift
Learn more in our new paper 👉 rdcu.be/d07Np
Learn more in our new paper 👉 rdcu.be/d07Np